| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.08 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.057 | 0.08 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.056 | 0.08 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.084 | 0.08 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.08 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.09 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |